Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL7020677

CC(OC(=O)/C=C\C(=O)O)c1ccco1.N

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 6/20 0.60
KMT2A Q03164 5/20 0.41
POLB P06746 5/20 0.41
BLM P54132 2/20 0.41
PKM P14618 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN7 P35236 1/20 0.41
ESR2 Q92731 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MASP2 O00187 1/20 0.40
F2 P00734 1/20 0.40
ALOX5 P09917 1/20 0.39
MEN1 O00255 4/20 0.38
TDP1 Q9NUW8 3/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28089141 0.98 HCAR2 (0.62) HCAR2KMT2APOLBBLMPKM
SCHEMBL28089140 0.92 HCAR2 (0.51) HCAR2KMT2APOLBBLMPKM
SCHEMBL27884913 0.80 KMT2A (0.42) HCAR2KMT2APOLBBLMPKM
SCHEMBL28079425 0.79 HCAR2 (0.47) HCAR2KMT2APOLBBLMPKM
SCHEMBL28109566 0.77 HCAR2 (0.44) HCAR2KMT2APOLBBLMPKM
Fumaric Acid SCHEMBL7020687 0.76 HCAR2 (0.49) HCAR2KMT2APOLBBLMPKM
Fumaric Acid SCHEMBL7020685 0.76 HCAR2 (0.49) HCAR2KMT2APOLBBLMPKM
SCHEMBL17868324 0.76 HCAR2 (1.00) HCAR2KMT2APOLBTDP1MAPT
SCHEMBL10339804 0.76 HCAR2 (1.00) HCAR2KMT2APOLBTDP1MAPT
SCHEMBL573378 0.76 HCAR2 (1.00) HCAR2KMT2APOLBTDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed